Biovica International AB (OSTO:BIOVIC B)
kr 2.6 0.2 (8.33%) Market Cap: 218.54 Mil Enterprise Value: 121.52 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 37/100

Biovica International AB Capital Markets Day (Virtual) Transcript

Jun 09, 2021 / 12:00PM GMT
Release Date Price: kr40.57
Anders Rylander;publ;CEO;Director
Biovica International AB

()-&

Hello, everyone, and welcome to the Biovica Capital Market Day of 2021. My name is Anders Rylander. I am the CEO of Biovica, and just a few words about my background, which is within management consultant, many years with Accenture and entrepreneurship where I co-founded management consulting company, Axholmen, which led to that I eventually came into contact with Biovica as an investor. And I was attracted by the great potential, both human and commercial, and the fact that we, with our product, can be beneficial for cancer patients on treatment and also for payers and health care providers. We'll get more into detail into that today. So now today, I'm both the CEO and the main shareholder of the company.

And talking about the agenda. And for today, we have 2.5 hours. We'll go through, first of all, a company overview, which I will do, then Dr. Malorni from Prato Hospital will take us through the oncologist perspective as he has a great experience from working with the testing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot